Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas
- 1 October 1997
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 183 (2) , 204-211
- https://doi.org/10.1002/(sici)1096-9896(199710)183:2<204::aid-path921>3.0.co;2-m
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotypeAnnals of Oncology, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- bcl-2 in cancer, development and apoptosisJournal of Cell Science, 1994
- The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor statusVirchows Archiv, 1994
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancerThe Breast, 1993
- Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinomaInternational Journal of Cancer, 1993
- Cell death by apoptosis during involution of the lactating breast in mice and ratsJournal of Anatomy, 1989
- Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breastBritish Journal of Cancer, 1981